Skip to main content

Glutamine News

Emmaus Life Sciences Receives FDA Approval for Endari Label Enhancements

Torrance CA, June 26, 2025 - Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, announced today that it has received Food and Drug Administration (FDA) approval for...

FDA Approves Endari (L-glutamine oral powder) for Sickle Cell Disease

July 7, 2017 – The U.S. Food and Drug Administration today approved Endari (L-glutamine oral powder) for patients age five years and older with sickle cell disease to reduce severe complications...

FDA Medwatch Alert: Sterile Drug Products by Bella Pharmaceuticals: Recall - Lack of Sterility Assurance

[Posted 08/18/2017] ISSUE: Bella Pharmaceuticals is voluntarily recalling all lots of unexpired sterile drug products due to lack of sterility assurance. The recalled products were distributed to ...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Dietary Supplementation

Glutamine patient information at Drugs.com